Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Adebrelimab manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

1 products found

adebrelimab

Injection 600 mg - 12 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #17216
This global pharmaceutical company, established in 1970, prioritizes research and development of innovative healthcare products. With a focus on oncology, metabolic diseases, autoimmune diseases, and cardiovascular diseases, they have developed 14 in-house innovative products and partnered with other companies to bring 2 more to market. They boast over 5,000 R&D personnel across fourteen global centers and subsidiaries in North America, the EU, Australia, and Japan. Their commitment to innovation is evidenced by over 90 innovative drug candidates in development and nearly 20 undergoing clinical trials worldwide. The company holds numerous patents granted in key regions like the US, EU, and Japan, demonstrating their strong intellectual property portfolio. They manufacture products that meet or exceed European Union and US Pharmacopoeia standards, exporting to markets including the US, EU, and Japan.

Manufacturer usually replies in 19 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible